MYCN and neuroblastoma: NBASP encoded by FAM201A is a potential therapeutic target. FABP5 knockdown reduces MYCN, survivin, and HMGA1 expression in NB. NSUN2-mediated m5C stabilizes FABP5 mRNA in OS, promoting fatty acid metabolism and tumor progression.